Health Economics Policy and Law

Papers
(The TQCC of Health Economics Policy and Law is 4. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-06-01 to 2026-06-01.)
ArticleCitations
HEP volume 17 issue 4 Cover and Back matter23
Genomics and insurance in the United Kingdom: increasing complexity and emerging challenges23
Fellow travellers in transformative times: a reflection on 21 years membership of the European Health Policy Group23
The contaminated blood scandal in England: exploring the social harms experienced by infected and affected individuals16
Reimbursement prices of new, innovative medicines in Germany: a comparison of negotiation and cost-effectiveness analysis15
New governance of the digital health agency: a way out of the joint decision trap to implement electronic health records in Germany?12
Priority setting for health equality – searching for an ethical framework12
Institutional boundaries and the challenges of aligning science advice and policy dynamics: the UK and Canada in the time of COVID-1911
From speculative to real: community attitudes towards government COVID-19 vaccine mandates in Western Australia from May 2021 to April 202211
Out with the old…10
Does elderly care suppress women’s fertility intentions? Quasi-experimental evidence from China’s home and community-based services reform10
Managed competition in Colombia: convergence of public and private insurance and delivery9
The relationship between healthcare provider ownership and performance in high-income countries: An umbrella review9
Politics in all policies: how healthcare is shaped by political (in)action8
Saving children's lives through interventions: a quasi-experimental analysis of GAVI8
Judicial claims for access to treatment in the private health insurance sector in Brazil8
Fair processes for financing universal health coverage?7
A review of heath economic evaluation practice in the Netherlands: are we moving forward?7
Making care primary: a renewed investment into primary care7
Preconditions for efficiency and affordability in mixed health systems: are they fulfilled in the Australian public–private mix?7
A European vision for telemedicine in cancer care: policy and patient perspectives from the eCAN Joint Action6
An examination of health care efficiency in Canada: a two-stage semi-parametric approach6
The state of American health coverage: the 2022 elections and the Affordable Care Act6
The changing landscape of PrEP deserts in the United States5
Neighborhood inequalities and the decline of infant mortality in São Paulo5
Exploring differences between public and private providers in primary care: findings from a large Swedish region5
Healthcare reform in the Netherlands: after 15 years of regulated competition5
Financial risk protection in private health insurance: empirical evidence on catastrophic and impoverishing spending from Germany's dual insurance system5
Acting reactively: private investment, controversies and regulatory and policy responses in residential long-term care in Ontario (Canada), Lombardy (Italy), the Netherlands and England (United Kingdo4
The roads to managed competition for mixed public–private health systems: a conceptual framework4
Promoting the systematic use of real-world data and real-world evidence for digital health technologies across Europe: a consensus framework4
Has regional decentralisation saved lives during the COVID-19 pandemic?4
Do consumers perceive and trust health insurers within a system of managed competition as prudent buyers of care?4
Primary care as determinant of COVID-19 and influenza vaccine uptake4
Political determinants of health: (re) examining the role of governance in reducing maternal mortality4
… and in with the new4
Navigating conflicting expectations in addressing healthcare scarcity: a q-methodology study on the Dutch National Health Care Institute4
Medical marijuana laws and mental health in the United States4
Market distortions in the Dutch mixed long-term care market: an exploratory analysis4
0.23051285743713